Sézary syndrome coexisting with B-cell chronic lymphocytic leukemia: Case report and review of the literature

Dermatology

Volumn 216, Issue 1, 2007, Pages 68-75

  Karsai, Syrus ^a   Hou, J Steve ^b   Telang, Gladys ^c   Kantor, Gary R ^d   Nowell, Peter C ^e   Vonderheid, Eric C ^f  

^a LASERKLINIK KARLSRUHE   (Germany)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d Dermpath Diagnostics   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Chronic lymphocytic leukemia; Cutaneous T cell lymphoma; Mycosis fungoides; S zary syndrome

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; FLUDARABINE; METHOTREXATE; PENTOSTATIN; PREDNISONE; PSORALEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

AGED; ARTICLE; ASCITES FLUID; B CELL LEUKEMIA; B LYMPHOCYTE; CANCER DIAGNOSIS; CASE REPORT; CELL LINEAGE; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CUTANEOUS T CELL LYMPHOMA; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; HUMAN; LOW DRUG DOSE; MALE; MEDICAL LITERATURE; MONOTHERAPY; MULTIPLE CANCER; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PUVA; SEPSIS; SEZARY SYNDROME; SKIN BIOPSY; T LYMPHOCYTE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; B-LYMPHOCYTES; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SEZARY SYNDROME; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 36349030296     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109362     Document Type: Article

References (59)

1. Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L, Olsen E, Pittelkow M, Russell-Jones R, Takigawa M, Willemze R: Update on erythrodermic cutaneous Tcell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002;46:95-106.
2. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ: WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-3785.
3. Bernengo MG, Novelli M, Quaglino P, Lisa F, De Matteis A, Savoia P, Cappello N, Fierro MT: The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol 2001;144:125-135.
4. Jones D, Dang NH, Duvic M, Washington LT, Huh YO: Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 2001;115:885-892.
5. Sentis HJ, Willemze R, Scheffer E: Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma. J Am Acad Dermatol 1986;15:1217-1226.
6. Trotter MJ, Whittaker SJ, Orchard GE, Smith NP: Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone. J Cutan Pathol 1997;24:286-291.
7. Russell-Jones R: Diagnosing erythrodermic cutaneous T-cell lymphoma. Br J Dermatol 2005;153:1-5.
8. Vonderheid EC: On the diagnosis of erythrodermic cutaneous T-cell lymphoma. J Cutan Pathol 2006;33(suppl 1):27-42.
9. Morice WG, Katzmann JA, Pittelkow MR, el-Azhary RA, Gibson LE, Hanson CA: A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome. Am J Clin Pathol 2006;125:364-374.
10. Bonvalet D, Foldes C, Civatte J: Cutaneous manifestations in chronic lymphocytic leukemia. J Dermatol Surg Oncol 1984;10:278-282.
11. Su WP, Buechner SA, Li CY: Clinicopathologic correlations in leukemia cutis. J Am Acad Dermatol 1984;11:121-128.
12. Cerroni L, Zenahlik P, Hofler G, Kaddu S, Smolle J, Kerl H: Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia. A clinicopathologic and prognostic study of 42 patients. Am J Surg Path 1996;20:1000-1010.
13. Volk AL, Vannucci SA, Cook W, Thompson KA, Listinsky CM: Composite mycosis fungoides and B-cell chronic lymphocytic leukemia. Ann Diagn Pathol 2002;6:172-182.
14. Parisi E, Clody P, Mazurier I, Grange F, Tortel MC, Moskovtchenko P: Simultaneous occurrence of Sézary syndrome and B-cell chronic lymphocytic leukaemia (in French). Ann Biol Clin 2003;61:94-98.
15. Gibbs SD, Herbert KE, McCormack C, Seymour JF, Prince HM: Alemtuzumab: effective immunotherapy for simultaneous B-cell chronic lymphocytic leukemia and Sézary syndrome. Eur J Haematol 2004;73:447-449.
16. Hallermann C, Kaune Kjell M, Tiemann M, Kunze E, Griesinger F, Mitteldorf C, Bertsch HP, Neumann C: High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage. Ann Hematol 2007;86:509-515.
17. Barzilai A, Trau H, David M, Feinmesser M, Bergman R, Shpiro D, Schiby G, Rosenblatt K, Or R, Hodak E: Mycosis fungoides associated with B-cell malignancies. Br J Dermatol 2006;155:379-386.
18. Sheibani K, Forman SJ, Winberg CD, Rappaport H: Coincidence of B-cell chronic lymphocytic leukemia and cutaneous T-cell lymphoma (mycosis fungoides): immunologic characterization by monoclonal antibodies. Blood 1983;62:1176-1181.
19. Peterman A, Jerdan M, Staal S, Bender B, Striecher H, Schupbach J, Resnick L: Evidence for HTLV-I associated with mycosis fungoides and B-cell chronic lymphocytic leukemia. Arch Dermatol 1986;122:568-571.
20. Aberer W, Groh V, Bettelheim P, Radaszkiewicz T, Wolff K:T- and B-cell double lymphoma: immunologic characterization using monoclonal antibodies (in German). Hautarzt 1988;39:388-392.
21. AlluéL, Domingo A, Moreno A, Crespo N, Marcoval J, Peyri J: Simultaneous occurrence of cutaneous T cell lymphoma and low-grade B cell lymphoproliferative diseases. A report of two cases. J Am Acad Dermatol 1990;23:677-681.
22. Harland CC, Whittaker SJ, Ng YL, Holden CA, Wong E, Smith NP: Coexistent cutaneous T-cell lymphoma and B-cell chronic lymphocytic leukaemia. Br J Dermatol 1992;127:519-523.
23. Liu YC, Tomashefski JF Jr, Cleveland RP, Nassar SJ, Trey JE: Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma:morphologic, immunologic, and molecular genetic documentation of concurrent lymph node involvement. Mod Pathol 1994;7:641-646.
24. Grange F, Avril MF, Esteve E, Joly P, Bosq J, de Murets A, Thomine E, Ortoli JC, Duvillard P, Vaillant L: Coexistent cutaneous Tcell lymphoma and B-cell malignancy. French Study Group on Cutaneous Lymphomas. J Am Acad Dermatol 1994;31:724-731.
25. Bateman AC, Hodges E, Quin CT, McCormick D, Barrett D, Smith JL: Cutaneous Tlymphocyte infiltrate associated with B-cell chronic lymphocytic leukaemia. Histopathology 1999;34:183-184.
26. Hull PR, Saxena A: Mycosis fungoides and chronic lymphocytic leukaemia - composite T-cell and B-cell lymphomas presenting in the skin. Br J Dermatol 2000;143:439-444.
27. Konstantopoulos K, Kapsimalis V, Vaiopoulos G, Kokkinis C, Papadaki T, Psarra K, Ekonomidou J: Simultaneous appearance of mycosis fungoides and chronic lymphocytic leukemia in the same patient. Haematologia 2000;30:41-43.
28. Agnew KL, Ruchlemer R, Catovsky D, Matutes E, Bunker CB: Cutaneous findings in chronic lymphocytic leukaemia. Br J Dermatol 2004;150:1129-1135.
29. Martinez A, Pittaluga S, Villamor N, Colomer D, Rozman M, Raffeld M, Montserrat E, Campo E, Jaffe ES: Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol 2004;28:849-858.
30. Bolli N, Di Ianni M, Simonetti S, Cerroni L, Liso A, Falini B, Tabilio A: Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy. Lancet Oncol 2004;5:64-65.
31. Süss A, Wetzig T, Sticherling M, Tannapfel A, Simon JC: Mycosis fungoides and B-cell chronic lymphocytic leukemia: an extremely rare coincidence (in German). Hautarzt 2006;57:888-892.
32. Kodama K, Fink-Puches R, Massone C, Kerl H, Cerroni L: Papular mycosis fungoides: a new clinical variant of early mycosis fungoides. J Am Acad Dermatol 2005;52:694-698.
33. Sexton FM, Maize JC: Follicular lymphomatoid papulosis. Am J Dermatopathol 1986;8:496-500.
34. Requena L, Sanchez M, Coca S, Sanchez Yus E: Follicular lymphomatoid papulosis. Am J Dermatopathol 1990;12:67-75.
35. Metzman MS, Stevens SR, Griffiths CE, Ross CW, Barnett JM, Cooper KD: A clinical and histologic mycosis fungoides simulant occurring as a T-cell infiltrate coexisting with B-cell leukemia cutis. J Am Acad Dermatol 1995;33:341-345.
36. Vonderheid EC, Bigler RD, Kotecha A, Boselli CM, Lessin SR, Bernengo MG, Polansky M: Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome). J Invest Dermatol 2001;117:654-662.
37. Reinhold U, Liu L, Sesterhenn J, Abken H: CD7-negative T cells represent a separate differentiation pathway in a subset of postthymic helper T cells. Immunology 1996;89:391-396.
38. Rappl G, Abken H, Muche JM, Sterry W, Tilgen W, Andre S, Kaltner H, Ugurel S, Gabius HJ, Reinhold U: CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death. Leukemia 2002;16:840-845.
39. Roberts AA, Amano M, Felten C, Galvan M, Sulur G, Pinter-Brown L, Dobbeling U, Burg G, Said J, Baum LG: Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation. Mod Pathol 2003;16:543-551.
40. Jones D, Ibrahim S, Patel K, Luthra R, Duvic M, Medeiros LJ: Degree of CD25 expression in T-cell lymphoma is dependent on tissue site: implications for targeted therapy. Clin Cancer Res 2004;10:5587-5594.
41. Hallermann C, Niermann C, Schulze HJ: Regulatory T-cell phenotype in association with large cell transformation of mycosis fungoides. Eur J Haematol 2007;78:260-263.
42. Roncador G, Garcia JF, Garcia JF, Maestre L, Lucas E, Menarguez J, Ohshima K, Nakamura S, Banham AH, Piris MA: FOXP3, a selective marker for a subset of adult T-cell leukaemia/ lymphoma. Leukemia 2005;19:2247-2253.
43. Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, Poenitz N, Sykora J, Banham AH, Roncador G, Kuhn A, Goerdt S, Krammer PH, Suri-Payer E: Paucity of FOXP3(+) cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas. Leukemia 2006;20:1123-1129.
44. Berger CL, Tigelaar R, Cohen J, Mariwalla K, Trinh J, Wang N, Edelson RL: Cutaneous Tcell lymphoma: malignant proliferation of Tregulatory cells. Blood 2005;105:1640-1647.
45. Wong HK, Wilson AJ, Gibson HM, Hafner MS, Hedgcock CJ, Berger CL, Edelson RL, Lim HW: Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides - cutaneous T cell lymphoma. J Invest Dermatol 2006;126:212-219.
46. Kwon S, Geskin L, Patton T, McCann S, Paley K, Falo LD Jr: CTCL patients exhibit elevated levels of regulatory T-cells that correspond with disease severity and response to treatment (abstract). J Invest Dermatol 2006;126:111.
47. Yuille MR, Matutes E, Marossy A, Hilditch B, Catovsky D, Houlston RS: Familial chronic lymphocytic leukaemia: a survey and review of published studies. Br J Haematol 2000;109, 794-799.
48. Hodak E, Klein T, Gabay B, Ben-Amitai D, Bergman R, Gdalevich M, Feinmesser M, Maron L, David M: Familial mycosis fungoides: report of 6 kindreds and a study of the HLA system. J Am Acad Dermatol 2005;52:393-402.
49. Hu E, Weiss LM, Warnke R, Sklar J: Non-Hodgkin's lymphoma containing both B and T cell clones. Blood 1987;70:287-292.
50. Feinberg AP, Ohlsson R, Henikoff S: The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006;7:21-33.
51. Madani A, Choukroun V, Soulier J, Cacheux V, Claisse JF, Valensi F, Daliphard S, Cazin B, Levy V, Leblond V, Daniel MT, Sigaux F, Stern MH: Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations. Blood 1996;87:1923-1927.
52. Narducci MG, Pescarmona E, Lazzeri C, Signoretti S, Lavinia AM, Remoti D, Scala E, Baroni CD, Stoppacciaro A, Croce CM, Russo G: Regulation of TCL1 expression in Band T-cell lymphomas and reactive lymphoid tissues. Cancer Res 2000;60:2095-2100.
53. Said JW, Hoyer KK, French SW, Rosenfelt L, Garcia-Lloret M, Koh PJ, Cheng TC, Sulur GG, Pinkus GS, Kuehl WM, Rawlings DJ, Wall R, Teitell MA: TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. Lab Invest 2001;81:555-564.
54. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D: TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood 2003;101:5007-5009.
55. Roos J, Hennig I, Schwaller J, Zbaren J, Dummer R, Burg G, Tobler A, Virgilio L, Croce CM, Fey MF, Borisch B: Expression of TCL1 in hematologic disorders. Pathobiology 2001;69:59-66.
56. Assaf C, Hummel M, Dippel E, Schwartz S, Geilen CC, Harder L, Siebert R, Steinhoff M, Klemke CD, Thiel E, Goerdt S, Stein H, Orfanos CE: Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomas. Br J Haematol 2003;120:488-491.
57. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D: A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 2004;104:328-335.
58. Yuille MR, Condie A, Stone EM, Wilsher J, Bradshaw PS, Brooks L, Catovsky D: TCL1 is activated by chromosomal rearrangement or by hypomethylation. Genes Chromosomes Cancer 2001;30:336-341.
59. Poenitz N, Simon-Ackermann J, Gratchev A, Qadoumi M, Klemke CD, Stadler R, Kremer A, Radenhausen M, Henke U, Assaf C, Utikal J, Goerdt S, Dippel E: Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. Dermatology 2005;211:84-92.